Reference number : 236-2017-2018-Q1-00636, amendment number : , agreement type : G, recipient legal name : Mckinnon, Lyle R, recipient country : CA, recipient province : MB, recipient city : Winnipeg, recipient postal code : R3T 2N2, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 249460.0, agreement start date : 2017-06-01, agreement end date : 2018-11-30, description english : Impact of Vedolizumab on immune cell homing to the female reproductive and gastrointestinal mucosa, description french : Impact of Vedolizumab on immune cell homing to the female reproductive and gastrointestinal mucosa, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2018-19), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2018-19), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada